Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Apr;21(4):659-64.
doi: 10.1002/oby.20026.

Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology

Affiliations
Review

Redefining metabolic syndrome as a fat storage condition based on studies of comparative physiology

Richard J Johnson et al. Obesity (Silver Spring). 2013 Apr.

Abstract

Objective: The metabolic syndrome refers to a constellation of signs including abdominal obesity, elevated serum triglycerides, low HDL-cholesterol, elevated blood pressure, and insulin resistance. Today approximately one third of the adult population has the metabolic syndrome. While there is little doubt that the signs constituting the metabolic syndrome frequently cluster, much controversy exists over the definition, pathogenesis, or clinical utility.

Design and methods: Here we present evidence from the field of comparative physiology that the metabolic syndrome is similar to the biological process that animals engage to store fat in preparation for periods of food shortage.

Results: We propose that the metabolic syndrome be changed to fat storage condition to more clearly align with its etiology. Obesity in humans is likely the consequences of both genetic predisposition (driven in part by thrifty genes) and environment. Recent studies suggest that the loss of the uricase gene may be one factor that predisposes humans to obesity today.

Conclusion: Understanding the process animals engage to switch from a lean insulin-sensitive to an obese insulin-resistant state may provide novel insights into the cause of obesity and diabetes in humans, and unique opportunities for reversing their pathology.

PubMed Disclaimer

Conflict of interest statement

Disclaimer/Conflict of Interest.

Dr Johnson is listed as an inventor on patent applications with the University of Florida related to lowering uric acid as a means for preventing or treating the metabolic syndrome. Dr Johnson and Dr Lanaspa are listed as inventors on patent applications from the University of Colorado on blocking fructose metabolism in the treatment of metabolic syndrome in response to carbohydrates. Finally, Dr. Johnson has a lay book, The Fat Switch (2012, Mercola.com) that discusses the role of fructose in metabolic syndrome in more detail. All other investigators have no conflicts.

Figures

Figure 1
Figure 1. The Metabolic Syndrome as a Disorder of Fat Storage
Many animals develop features consistent with metabolic syndrome as part of the normal physiological processes involved in fat storage (shown as dotted lines). This suggests that metabolic syndrome may represent a form of fat storage. However, most animals undergo a period of fasting that brings the animal back to their regular weight, whereas many humans will progressively increase their fat stores until they become frankly obese or diabetic (solid lines).
Figure 2
Figure 2. Parallel Mutations in Uricase occurred During the Evolution of Hominoids in the Miocene
Adapted from Johnson RJ et al with permission of Elsevier.
Figure 3
Figure 3. The Thrifty Gene Hypothesis and Uricase
The uricase mutation occurred during global cooling in the mid Miocene and has been postulated to have provided a survival advantage to European apes who were undergoing periodic starvation due to the loss of fruit availability in the cooler seasonal months. Specifically, the mutation amplified the effects of fructose in fruits to increase fat stores. Later the introduction of sugar led to a major increase in fructose availability and likely has a role in the epidemic rise in obesity and diabetes.

Comment in

References

    1. Kylin E. [Studies of the hypertension-hyperglycemia-hyperuricemia syndrome] Studien uber das Hypertonie-Hyperglykamie-hyperurikamiesyndrome. Zentralblatt fur innere Medizin. 1923;44:105–127.
    1. Herman JB, Medalie JH, Goldbourt U. Diabetes, prediabetes and uricaemia. Diabetologia. 1976;12:47–52. - PubMed
    1. Haller H. [Epidemiology and associated risk factors of hyperlipoproteinemia] Z Gesamte Inn Med. 1977;32:124–128. - PubMed
    1. Phillips GB. Relationship between serum sex hormones and glucose, insulin and lipid abnormalities in men with myocardial infarction. Proceedings of the National Academy of Sciences of the United States of America. 1977;74:1729–1733. - PMC - PubMed
    1. Singer P. [Diagnosis of primary hyperlipoproteinemias] Z Gesamte Inn Med. 1977;32:128. contd. - PubMed

Publication types

MeSH terms

LinkOut - more resources